Dynamic ROM Via Gait Analysis and 3D Fluoroscopy in THA With Different Head Diameters
DROMDP
Dynamic Range of Motion (ROM) Assessment Using Gait Analysis and Three-dimensional Fluoroscopy in Patients Treated by Total Hip Arthroplasty (THA) With Different Head Diameters
1 other identifier
interventional
30
1 country
1
Brief Summary
Pain and reduced function are the most common symptoms of coxarthritis. Pain relief and normal range of motion (ROM) restoration are the objectives of a Total Hip Arthroplasty (THA) procedure. It is recognized that increased head-neck ratio results in increased ROM due to the fact that prosthetic impingement between neck and acetabular liner occurs with wider arcs of motion. This head-neck ratio has been investigated extensively only in vitro (on cadavers or sawbones) or using mathematical modeling in computer simulations. These studies are limited by the lack of soft tissues and muscle activations in the models. This study will clinically assess the effect of prosthetic head diameter on patient capability of performing movements which require extreme arcs of motion of the hip joint. Therefore, the research questions are:
- What role do soft tissues play in limiting ROM?
- Can prosthetic impingement really occur in a well positioned THA?
- Can a bigger head diameter alone reduce the risk of impingement?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 22, 2014
CompletedFirst Posted
Study publicly available on registry
January 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2017
CompletedFebruary 17, 2020
February 1, 2020
2.1 years
January 22, 2014
February 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants and Hip Joint Positions with the Occurrence of Implant Impingement
Three-dimension videofluoroscopy is used to calculate prosthesis component relative pose, and to estimate minimum distance at the areas of risk of impingement
12 months
Number of Participants with Functional Deficits at the Hip Joint as Measured by Gait Analysis
Three-dimension kinematics and kinetics of the trunk, pelvis and lower limb joints is used during level walking and other motor tasks, as well as for the single exercises of hip joint extreme motion analyzed in videofluoroscopy, to assess thoroughly those patients with and without impingement.
12 months
Secondary Outcomes (4)
Range of Motion of the operated hip versus contralateral non-operated hip
12 months
Correlations between prosthetic head diameter and hip functional scores
12 months
Standard Clinical Hip Scores
pre-op, and 12 months
X-ray measurements
12 months
Study Arms (3)
THA28
ACTIVE COMPARATORTHA Corail PinnacleCoC28
THA36
ACTIVE COMPARATORTHA Corail DeltaMotion36
THA40
ACTIVE COMPARATORTHA Corail DeltaMotion40
Interventions
Uncemented THA with Corail stem and Pinnacle acetabular cup with CoC 28 mm head
Uncemented THA with Corail stem and DeltaMotion acetabular cup with 36 mm head
Uncemented THA with Corail stem and DeltaMotion acetabular cup with 40 mm head
Eligibility Criteria
You may qualify if:
- Patients with unilateral primary or secondary hip arthrosis indicated for THA;
- Men and female, age between 35 and 55 years old;
- BMI smaller than 30;
- Patients able to understand the protocol and to sign the informed consent.
You may not qualify if:
- Child-bearing female;
- Patients with also controlateral hip arthritis;
- Neurological patients, because of possible alteration of neuro-muscular control of the replaced hip;
- Patients treated with joint replacement at any other lower limb articulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istituto Ortopedico Rizzolilead
- DePuy Internationalcollaborator
Study Sites (1)
Istituto Ortopedico Rizzoli
Bologna, BO, 40136, Italy
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandro Giannini, MD, Prof
Istituto Ortopedico Rizzoli
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Alberto Leardini
Study Record Dates
First Submitted
January 22, 2014
First Posted
January 28, 2014
Study Start
January 1, 2014
Primary Completion
February 1, 2016
Study Completion
December 21, 2017
Last Updated
February 17, 2020
Record last verified: 2020-02